White label ELPA - ClinicalTrials.eu

Study on the Effects of Fipaxalparant in Patients with Diffuse Cutaneous Systemic Sclerosis

Not recruiting

2 1
Investigated diseases:
- Systemic scleroderma
+3
Study of Eftilagimod Alpha and Paclitaxel in Patients with HER2-Negative/Low Metastatic Breast Cancer

Not recruiting

4 1 1
Investigated diseases:
- Breast cancer stage IV
Study on the Effects of Pembrolizumab, Atezolizumab, and Nivolumab in Patients with Advanced Non-Small Cell Lung Cancer

Not recruiting

2 1 1 1
Investigated diseases:
- Non-small cell lung cancer
Study on Oral Glibenclamide for Managing High Blood Sugar in Premature Infants Weighing Less Than 1500g

Not recruiting

2 1 1 1
Investigated diseases:
- Neonatal hyperglycaemia
Long-term study of upadacitinib tablets for adults with Crohn’s disease

Not recruiting

2 1 1
Investigated diseases:
- Crohn’s disease
Study on Nanatinostat and Valganciclovir for Patients with Epstein-Barr Virus-Positive Relapsed or Refractory Lymphomas

Not recruiting

2 1 1 1
Investigated diseases:
- Epstein-Barr virus associated lymphoma
Study of datopotamab deruxtecan combined with immunotherapy and carboplatin in patients with advanced or metastatic non-small cell lung cancer

Not recruiting

1 1 1 1
Investigated diseases:
- Non-small cell lung cancer
Study on the Effects of Riliprubart for Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Not recruiting

2 1 1 1
Investigated diseases:
- Chronic inflammatory demyelinating polyradiculoneuropathy
Study on Melanoma Treatment: Comparing Encorafenib and Binimetinib with Ipilimumab and Nivolumab for Patients with BRAF V600 Mutation

Not recruiting

2 1 1 1
Study on Livmoniplimab and Budigalimab with Chemotherapy for Adults with Untreated Metastatic Non-Small Cell Lung Cancer

Not recruiting

4 1 1 1

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies